4.7 Article

Human β-cell Proliferation and Intracellular Signaling: Driving in the Dark Without a Road Map

期刊

DIABETES
卷 61, 期 9, 页码 2205-2213

出版社

AMER DIABETES ASSOC
DOI: 10.2337/db12-0018

关键词

-

资金

  1. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/National Institutes of Health (NIH) [R01-DK-67536, R21-RR-24905]
  2. Juvenile Diabetes Research Foundation (JDRF) [17-2011-644]
  3. NIDDK/NIH [R01-DK-73716, R01-DK-84236, R01-DK-77096, R01-DK-67351]
  4. JDRF [46-2010-758, 1-2008-39, 34-2008-630]
  5. American Diabetes Association (ADA) [7-06-CD-02]
  6. ADA [1-10-BS-59]
  7. NIDDK
  8. Beta Cell Biology Consortium through NIH [U01-DK-089538, R01-DK-55023]

向作者/读者索取更多资源

A major goal in diabetes research is to find ways to enhance the mass and function of insulin secreting beta-cells in the endocrine pancreas to prevent and/or delay the onset or even reverse overt diabetes. In this Perspectives in Diabetes article, we highlight the contrast between the relatively large body of information that is available in regard to signaling pathways, proteins, and mechanisms that together provide a road map for efforts to regenerate beta-cells in rodents versus the scant information in human beta-cells. To reverse the state of ignorance regarding human beta-cell signaling, we suggest a series of questions for consideration by the scientific community to construct a human beta-cell proliferation road map. The hope is that the knowledge from the new studies will allow the community to move faster towards developing therapeutic approaches to enhance human beta-cell mass in the long-term goal of preventing and/or curing type 1 and type 2 diabetes. Diabetes 61:2205-2213, 2012

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据